Concepedia

Zhuangqi Li

ZL

3

Publications

78

Citations

3

H-Index

2022

Active since

Affiliations

National Medical Products Administration(Current)

Tsinghua University

Center for Life Sciences

Fudan University

Duke University

Zhuangqi Li is an author at National Medical Products Administration specializing in drug discovery, cancer research, and pre-clinical pharmacology.

Top concepts

MedicineOncologyDrug SafetyPharmacologyPublic HealthDrug DiscoveryCancer ResearchClinical TrialsDrug MonitoringPharmacotherapy

Publications per year

2022–2023

3

Publications

3

Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021

Xingxian Luo, Xin Du, Zhuangqi Li et al. · Clinical Pharmacology & Therapeutics · 2022 · 33 citations

Preclinical Therapeutics, Pharmacotherapy, United States +22

The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis

Xingxian Luo, Xin Du, Lin Huang et al. · The Lancet Regional Health - Western Pacific · 2022 · 25 citations · Full text

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022

Xingxian Luo, Xin Du, Lin Huang et al. · EClinicalMedicine · 2023 · 20 citations · Full text

Rows per page

1–3 of 3